InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,868.40
(
-0.79%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.04
(
-0.21%
)
Bitcoin
64,176.86
(
-0.16%
)
Post# of 251590
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 44
Posts 4523
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: biocqr post# 220840

Friday, 09/14/2018 9:49:02 AM

Friday, September 14, 2018 9:49:02 AM

Post# of 251590
it's odd that EOLS has not dropped in line w RVNC (yet)
perhaps people think that interest in a short acting neurotoxin has negative implications for a long acting product like RVNC. In frown lines i can see someone wanting a short acting as a first step and if they like it then moving to long acting - something that could expand the market IMO so i dont think a negative for revance
JMO
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up